August 23, 2007 — The FDA has approved Reclast (zoledronic acid) Injection, the first and only once-yearly treatment for postmenopausal osteoporosis.
Approximately 8 million women in the United States suffer from osteoporosis, a disease characterized by low bone mass and reduced bone strength that causes bones to break easily. Osteoporotic fractures are associated with increased morbidity, mortality and healthcare costs.